CHANG NANCY T 4
4 · Immix Biopharma, Inc. · Filed Dec 11, 2025
Insider Transaction Report
Form 4
CHANG NANCY T
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-11-21+39,643→ 39,643 totalExercise: $4.33Exp: 2035-11-21→ Common Stock (39,643 underlying)
Holdings
- 421,940
Common Stock
- 496,940(indirect: Held by Robinhood II, LP)
Common Stock
Footnotes (2)
- [F1]Dr. Nancy T. Chang is the general manager of Robinhood II, LP and may be deemed to beneficially own the securities held by Robinhood II, LP. Dr. Chang disclaims beneficial ownership of the common stock owned directly by Robinhood II, LP, except to the extent of her pecuniary interest therein.
- [F2]The Stock Option will vest in thirty-six (36) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer and the terms of a Stock Option Agreement entered into to evidence the award.